Zivo Bioscience Inc (ZIVO)

[Amigo Mike]

Algaeboy,

My opinion is ZIVO has some investor interest but can't invest unless the stock is listed.

Listing requirements are pretty straightforward. ZIVO as it stands doesn't qualify on the majority of requirements.

https://listingcenter.nasdaq.com/Assets/Initialguide.pdf

Column 1 under the Nasdaq Capital Market is their only shot I believe.

Current Shareowner Equity is negative as I recall. So, can't list without the raise, can't get the raise without the listing. Can't further qualify for the listing without RS. Certainly possible Nasdaq sez no ..... and potentially that means no raise. The S-1 makes it sound like no raise if no list.

Listing on the Nasdaq Capital Market

Our Common Stock is currently quoted on the OTCQB Market. In connection with this Offering, we have applied to list our Common Stock and warrants offered in the Offering on the Nasdaq Capital Market (“Nasdaq”) under the symbols “ZIVO” and “ZIVOW”, respectively. If our listing application is approved, we expect to list our Common Stock and the warrants offered in the Offering on Nasdaq upon consummation of the Offering, at which point our Common Stock will cease to be traded on the OTCQB Market. No assurance can be given that our listing application will be approved. This Offering will occur only if Nasdaq approves the listing of our Common Stock and warrants. Nasdaq listing requirements include, among other things, a stock price threshold. As a result, prior to effectiveness, we will need to take the necessary steps to meet Nasdaq listing requirements, including but not limited to a reverse split of our outstanding Common Stock. If Nasdaq does not approve the listing of our Common Stock, we will not proceed with this Offering. There can be no assurance that our Common Stock will be listed on the Nasdaq.

Pretty sure ZIVO meets all governance and filing requirements excepting one BoD committee noted in the S-1. That's just a matter of pen on paper and creating one.

So, RS required to list. Raise is required to list. But raise dependent on list. Dunno if Nasdaq would allow that.

I'm ok will all of that .... but if mgmt cannot change their tune, there won't be any upside in the stock unfortunately. Big boy listing comes with big boy investors. If mgmt can't get the job done, and quickly, well won't be surprised to see big boys SHORTS destroying this stock.

A stock and its price aren't really about the financials of a company. IT IS ALL ABOUT THE SENTIMENT THAT SURROUNDS THE STOCK. Easy case in point is a number of the stocks you've all heard about that are racing to amazing high prices yet could never do enough business in the next 5 years to justify such a price. IT IS SENTIMENT, NOT REALITY. Dahl does not know how to do this, nor do I think he cares. His mantra has been get to commercial stage and the price with take care of itself. 100% UNEQUIVOCABLY WRONG That is just one of many reasons it is another problem if Dahl remains CEO. Again, imagine Dahl and Rice on a qtrly conference call.

Bottomline for me, mgmt is the biggest issue holding this company back and moving to Nasdaq will only put a bigger spotlight on it.

Amigo Mike